Scientists reveal new clues to Alzheimer's risk gene

July 27, 2012
Scientists reveal new clues to Alzheimer's risk gene
New clues into Alzheimer’s risk gene

(Medical Xpress) -- A study by scientists at the University of Southampton has revealed new clues to why people who carry the Alzheimer's risk gene APOE4 may be more likely to develop the disease.

The findings, which link the risk gene to clearance of the hallmark ’s protein amyloid, take scientists a step further towards understanding the devastating disease. The research, published on July 25 in the journal PLoS ONE, was funded by Alzheimer’s Research UK.

The APOE gene is the biggest known genetic risk factor for late-onset Alzheimer’s disease. People who carry the APOE4 version of the gene have a higher risk of developing the disease at an earlier age than people who carry APOE3 or APOE2. However, the reason for this increased risk has remained unclear.

One of the key features of Alzheimer’s disease is the build-up of a toxic protein called amyloid in the brain. Higher levels of amyloid have been reported in blood vessels in the brains of people with APOE4, causing a condition called cerebral amyloid angiopathy (CAA). It is thought that CAA may contribute to Alzheimer’s and the Southampton team, who specialise in studying blood vessels in the brain, set out to investigate this link further.

To examine the effect of the risk gene in the brain, the scientists used normal mice and mice bred to have human versions of either APOE4 or its neutral equivalent APOE3. They looked at the levels of amyloid in the blood vessels of these mice using a fluorescently labelled version of the protein that they could track.

Dr Cheryl Hawkes, from the University of Southampton, an author on the study, says: “We found that only the mice with APOE4 had high levels of amyloid in the blood vessels of their brain, suggesting that people with the risk gene may not be able to clear the toxic protein as effectively from their brain. After delving a little deeper, we discovered that the in mice with were very different – they were made up of a different set of components that may not work as well to clear amyloid.

“These initial results are really exciting because they help us to build a bigger picture of the factors influencing a person’s risk of Alzheimer’s. The next step will be to move this study from mice into humans to confirm that we see a similar change.”

Dr Simon Ridley, Head of Research at Alzheimer’s Research, said: “Our understanding of the factors that make up a person’s risk of Alzheimer’s is improving at an incredible rate. Across our lifestyle and the environment, our age, diet and our , the answers to what predisposes us to Alzheimer’s are being found. Research like this makes the risk picture more complete, and moves us closer to developing new treatments and preventions that can avert this devastating disease.

“There are around half a million people in the UK living with Alzheimer’s disease, yet research into dementia remains hugely underfunded compared to other common diseases. If we are to make a real different to the lives of people with this devastating disease, we must continue to invest in research.”

Explore further: ApoE4 Alzheimer's gene causes brain's blood vessels to leak, die

Related Stories

ApoE4 Alzheimer's gene causes brain's blood vessels to leak, die

May 16, 2012
Common variants of the ApoE gene are strongly associated with the risk of developing late-onset Alzheimer's disease, but the gene's role in the disease has been unclear. Now, researchers funded by the National Institutes ...

Scientists find increased ApoE protein levels may promote Alzheimer's disease

April 3, 2012
Scientists at the Gladstone Institutes have enhanced our understanding of how a protein linked to Alzheimer's disease keeps young brains healthy, but can damage them later in life—suggesting new research avenues for ...

Recommended for you

Study shows video games could cut dementia risk in seniors

November 16, 2017
Could playing video games help keep the brain agile as we age?

New player in Alzheimer's disease pathogenesis identified

November 14, 2017
Scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) have shown that a protein called membralin is critical for keeping Alzheimer's disease pathology in check. The study, published in Nature Communications, ...

Biomarker may predict early Alzheimer's disease

November 10, 2017
Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a peptide that could lead to the early detection of Alzheimer's disease (AD). The discovery, published in Nature Communications, may ...

Smell test challenge suggests clinical benefit for some before development of Alzheimer's

November 10, 2017
Researchers at Columbia University Medical Center (CUMC) and the New York State Psychiatric Institute (NYSPI) may have discovered a way to use a patient's sense of smell to treat Alzheimer's disease before it ever develops. ...

How SORLA protects against Alzheimer's disease

November 7, 2017
Researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) have identified a new protective function for a brain protein genetically linked to Alzheimer's. The findings, published in the Journal of Experimental ...

Saving neurons may offer new approach for treating Alzheimer's disease

November 6, 2017
Treatment with a neuroprotective compound that saves brain cells from dying also prevents the development of depression-like behavior and the later onset of memory and learning problems in a rat model of Alzheimer's disease. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.